Pay in 4 interest-free payments of $7.44 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
According to CNN, more than 70% of semaglutide prescriptions have gone to White patients White people are about four times more likely than Black people to have a prescription for a semaglutide medication, despite having nearly a 40% lower prevalence of diabetes and a 17% lower prevalence of obesity. So, White patients are receiving the vast majority of semaglutide prescriptions (Ozempic and Wegovy) by percentage, despite having a lower prevalence of both diabetes and obesity
Popik, P., Kos, T., Zhang, Y
With the success of landmark cardiovascular outcome trials on glucagon-like peptide-1 receptor agonist (GLP-1RA) and sodium-glucose cotransporter-2 inhibitors (SGLT2i) [10], this has transformed the landscape of cardiometabolic disease management [11]
Lipoprotein(a) is markedly more atherogenic than LDL: an apolipoprotein B-based genetic analysis
Weight Loss Surgery: What Patients Should Know in 2026 Oral GLP-1 medications are changing the weight loss conversation
Based on GLP-1 receptor agonist class data, reducing the dose would be expected to produce less appetite suppression and a slower rate of weight loss or potential weight regain, as the pharmacological effect is dose-dependent
